Drawing for BEYOND HUMAN (IN)SIGHT

USPTO serial 98758329

BEYOND HUMAN (IN)SIGHT

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
CAHILL, CLARE GALLAGHER
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with BEYOND HUMAN (IN)SIGHT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Holly Pranger

Holly Pranger Pranger Law PC88 Guy Place, Suite 405San Francisco, CA 94105United States

Goods and services

ClassDescriptionStatusFirst use
009Computer hardware and apparatus for recording, transmission, and reproduction of images; Computer hardware and apparatus for image processing, namely, computers, image intensifiers, computer display monitors, and video cameras; Downloadable software for medical analysis or advisory services relating to the palliation or treatment of diseases, states, or conditions; Downloadable software for qualitative image analysis in the field of digital cytology for medical purposes; Downloadable software for quantitative image analysis in the field of digital cytology for medical purposes; Downloadable software for data ingestion, data analysis, data visualization, predictive data analysis, modeling, data preparation, digitizing data, data transformation, data augmentation, integration into a data framework, and data encryption from lab pathologies; Downloadable software for transferring slides, images, and data featuring lab cytology for disease; Downloadable software for use in displaying, viewing, storing, visualizing, filtering, assessing, and analyzing digital images; Downloadable software for use in classification and reclassifying data for medical and diagnostic purposes; Downloadable software for use in medical database management for disease diagnosis; Downloadable software for use in analyzing data of cancerous diseases; Downloadable software for data analysis; Downloadable software for data processing; Downloadable software for diagnosing diseases for medical purposes; Downloadable software for scientific and technical analysis of data using artificial intelligence (AI); Downloadable software using artificial intelligence for diagnosing diseases for medical purposesACTIVE—
010Medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology, and cell-based testing; Medical diagnostic apparatus with computer displays, computer hardware, and recorded software for processing medical imagesACTIVE—
042Providing online non-downloadable software for artificial intelligence processing, machine learning, deep learning, statistical learning, data mining, and contextual prediction in the fields of medicine, healthcare, pathology, cytology, diagnostics, and diseases and disorders; Providing online non-downloadable software for reading digital slides; Providing online non-downloadable software for use in diagnosis of diseases, states, or conditions; Providing online non-downloadable software for use in evaluation of prognosis relating to diseases, states, or conditions; Providing online non-downloadable software for use in research or development in the field of cytology; Providing online non-downloadable software using artificial intelligence for cancer detection, decision support and image analysis for healthcare; Providing online non-downloadable software using artificial intelligence and machine learning for medical diagnostic use in the fields of cancer or other tissue-based diagnostic testing, cytology, and cell-based testing; Providing online non-downloadable software for scanning, viewing, analyzing, annotating, storing, compiling, sharing, reviewing, enhancing, and managing medical image data; Digital pathology services, in particular web-based pathology services in the nature of providing online non-downloadable software for scanning, viewing, analyzing, annotating, storing, compiling, sharing, reviewing, enhancing, and managing medical image data; Providing online non-downloadable software for processing digital imagesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 6, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 5, 2026EX1GSOU EXTENSION 1 GRANTED—
Nov 5, 2026EXT1SOU EXTENSION 1 FILED—
Nov 5, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 13, 2026NOACCORRECTED NOA E-MAILED—
May 5, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 10, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 10, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 11, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 1, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jul 31, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 31, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Jul 31, 2025CNSLSUSPENSION LETTER WRITTEN—
Jun 27, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 27, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 27, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 1, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 26, 2025DOCKASSIGNED TO EXAMINER—
Mar 25, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 19, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance